ResMed names Carol Burt as lead director, Ron Taylor to retire
SAN DIEGO - ResMed (NYSE:RMD, ASX: RMD) announced today that Carol Burt will become Lead Director on November 15, 2026, according to a press release statement. She will succeed Ron Taylor, who will retire after more than 21 years on the company’s Board of Directors.
Reported by 1 outlet — Investing.com · Company News. See all sources ↓
SAN DIEGO - ResMed (NYSE:RMD, ASX: RMD) announced today that Carol Burt will become Lead Director on November 15, 2026, according to a press release statement. She will succeed Ron Taylor, who will retire after more than 21 years on the company’s Board of Directors. Taylor, who joined ResMed’s Board in 2005 and has served as Lead Director since 2013, is not standing for reelection at the company’s Annual Meeting of Stockholders on November 18, 2026. Burt has served on ResMed’s Board since 2013 and currently chairs the Nominating and Governance Committee.
Read the full report at Investing.com · Company News ↗
Why it matters
A world story we're tracking; its significance and source trust firm up as more outlets confirm it.
- What's the story?
- SAN DIEGO - ResMed (NYSE:RMD, ASX: RMD) announced today that Carol Burt will become Lead Director on November 15, 2026, according to a press release statement. She will succeed Ron Taylor, who will retire after more than 21 years on the company’s Board of Directors.
- How widely is it covered?
- 1 outlet, average source rating 5.0/10.
- When was it last updated?
- 1m ago.
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
ResMed names Carol Burt as lead director, Ron Taylor to retire
Sources1TypeCoverageInvesting.com · Company News